Doctolib has 6 close competitors: Signos, Abridge, Alloy Therapeutics.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
DoctolibSignosAbridgeBenchlingCMR SurgicalCommureDoctolib is a Paris-region healthtech company offering exposure to a booking, telemedicine and practice-management platform used by medical professionals across France, Germany and Italy.
Doctolib competes with 6 companies here: Signos, Abridge, Alloy Therapeutics, Benchling, CMR Surgical, Commure.
Doctolib was last valued at $6.4B (post-money, Mar 2022). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $6.4B.
Lead investors for each round are in the funding timeline.
The closest healthtech / medical appointment booking peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
